These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 19482505)

  • 21. The GIGYF2 variants are not associated with Parkinson's disease in the mainland Chinese population.
    Cao L; Zhang T; Zheng L; Wang Y; Wang G; Zhang J; Fei QZ; Cui PJ; Wang XJ; Ma JF; Xiao Q; Chen SD
    Parkinsonism Relat Disord; 2010 May; 16(4):294-7. PubMed ID: 20044296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Molecular genetics of Parkinson's disease.
    Gasser T
    Adv Neurol; 2001; 86():23-32. PubMed ID: 11553982
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of replication of association between GIGYF2 variants and Parkinson disease.
    Bras J; Simón-Sánchez J; Federoff M; Morgadinho A; Januario C; Ribeiro M; Cunha L; Oliveira C; Singleton AB
    Hum Mol Genet; 2009 Jan; 18(2):341-6. PubMed ID: 18923002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GIGYF2 mutation in late-onset Parkinson's disease with cognitive impairment.
    Ruiz-Martinez J; Krebs CE; Makarov V; Gorostidi A; Martí-Massó JF; Paisán-Ruiz C
    J Hum Genet; 2015 Oct; 60(10):637-40. PubMed ID: 26134514
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is GIGYF2 the defective gene at the PARK11 locus?
    Bonifati V
    Curr Neurol Neurosci Rep; 2009 May; 9(3):185-7. PubMed ID: 19348706
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The contribution of GIGYF2 to Parkinson's disease: a meta-analysis.
    Zhang Y; Sun QY; Yu RH; Guo JF; Tang BS; Yan XX
    Neurol Sci; 2015 Nov; 36(11):2073-9. PubMed ID: 26152800
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PARK11 gene (GIGYF2) variants Asn56Ser and Asn457Thr are not pathogenic for Parkinson's disease.
    Zimprich A; Schulte C; Reinthaler E; Haubenberger D; Balzar J; Lichtner P; El Tawil S; Edris S; Foki T; Pirker W; Katzenschlager R; Daniel G; Brücke T; Auff E; Gasser T
    Parkinsonism Relat Disord; 2009 Aug; 15(7):532-4. PubMed ID: 19250854
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GIGYF2 gene disruption in mice results in neurodegeneration and altered insulin-like growth factor signaling.
    Giovannone B; Tsiaras WG; de la Monte S; Klysik J; Lautier C; Karashchuk G; Goldwurm S; Smith RJ
    Hum Mol Genet; 2009 Dec; 18(23):4629-39. PubMed ID: 19744960
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Variation in GIGYF2 is not associated with Parkinson disease.
    Nichols WC; Kissell DK; Pankratz N; Pauciulo MW; Elsaesser VE; Clark KA; Halter CA; Rudolph A; Wojcieszek J; Pfeiffer RF; Foroud T;
    Neurology; 2009 Jun; 72(22):1886-92. PubMed ID: 19279319
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Summary of GIGYF2 studies in Parkinson's disease: the burden of proof.
    Tan EK; Schapira AH
    Eur J Neurol; 2010 Feb; 17(2):175-6. PubMed ID: 19906271
    [No Abstract]   [Full Text] [Related]  

  • 31. Mutations in VPS26A are not a frequent cause of Parkinson's disease.
    Koschmidder E; Mollenhauer B; Kasten M; Klein C; Lohmann K
    Neurobiol Aging; 2014 Jun; 35(6):1512.e1-2. PubMed ID: 24417787
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Meta-analyses of seven
    Dai D; Wang Y; Zhou X; Tao J; Jiang D; Zhou H; Jiang Y; Pan G; Ru P; Ji H; Li J; Zhang Y; Yin H; Xu M; Duan S
    Biomed Rep; 2014 Nov; 2(6):886-892. PubMed ID: 25279164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Asp620asn mutation in VPS35 is not a common cause of familial Parkinson's disease.
    Guella I; Soldà G; Cilia R; Pezzoli G; Asselta R; Duga S; Goldwurm S
    Mov Disord; 2012 May; 27(6):800-1. PubMed ID: 22278960
    [No Abstract]   [Full Text] [Related]  

  • 34. A new F-box protein 7 gene mutation causing typical Parkinson's disease.
    Lohmann E; Coquel AS; Honoré A; Gurvit H; Hanagasi H; Emre M; Leutenegger AL; Drouet V; Sahbatou M; Guven G; Erginel-Unaltuna N; Deleuze JF; Lesage S; Brice A
    Mov Disord; 2015 Jul; 30(8):1130-3. PubMed ID: 26010069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LRP10 in autosomal-dominant Parkinson's disease.
    Chen Y; Cen Z; Zheng X; Pan Q; Chen X; Zhu L; Chen S; Wu H; Xie F; Wang H; Yang D; Wang L; Zhang B; Luo W
    Mov Disord; 2019 Jun; 34(6):912-916. PubMed ID: 30964957
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GIGYF2 variants are not associated with Parkinson's disease in Italy.
    Bonetti M; Ferraris A; Petracca M; Bentivoglio AR; Dallapiccola B; Valente EM
    Mov Disord; 2009 Sep; 24(12):1867-8; author reply 1868-9. PubMed ID: 19562763
    [No Abstract]   [Full Text] [Related]  

  • 37. A clinical genetic study of Parkinson's disease: evidence for dominant transmission.
    Lazzarini AM; Myers RH; Zimmerman TR; Mark MH; Golbe LI; Sage JI; Johnson WG; Duvoisin RC
    Neurology; 1994 Mar; 44(3 Pt 1):499-506. PubMed ID: 8145922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Valosin-containing protein mutation and Parkinson's disease.
    Chan N; Le C; Shieh P; Mozaffar T; Khare M; Bronstein J; Kimonis V
    Parkinsonism Relat Disord; 2012 Jan; 18(1):107-9. PubMed ID: 21816654
    [No Abstract]   [Full Text] [Related]  

  • 39. Familial aggregation of Parkinson's disease.
    de la Fuente-Fernández R; Calne DB
    N Engl J Med; 2001 Apr; 344(15):1168. PubMed ID: 11302144
    [No Abstract]   [Full Text] [Related]  

  • 40. Association study of DNAJC13, UCHL1, HTRA2, GIGYF2, and EIF4G1 with Parkinson's disease.
    Saini P; Rudakou U; Yu E; Ruskey JA; Asayesh F; Laurent SB; Spiegelman D; Fahn S; Waters C; Monchi O; Dauvilliers Y; Dupré N; Greenbaum L; Hassin-Baer S; Espay AJ; Rouleau GA; Alcalay RN; Fon EA; Postuma RB; Gan-Or Z
    Neurobiol Aging; 2021 Apr; 100():119.e7-119.e13. PubMed ID: 33239198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.